Duration: (50:5) ?Subscribe5835 2025-02-19T09:17:34+00:00
Webinar: Commercializing the Nu.Q® Vet Cancer Test.
(17:36)
VolitionRx – Commercializing the Nu.Q Vet Cancer Test: Webinar
(36:37)
VolitionRx webinar: Unravelling the web of NETs in sepsis … Part II
(56:4)
VolitionRx webinar: Unravelling the web of NETs in sepsis
(56)
VolitionRx webinar: Breakthrough liquid biopsy method for cancer detection
(50:5)
Webinar - Breakthrough Cancer Detection Method
(23:1econd)
VolitionRx Limited (NYSE American: VNRX) Webcast | Planet MicroCap Showcase: VIRTUAL 2022
(24:34)
VolitionRx Breaks Down Supply Agreement of Nu.Q® Vet Cancer Tests with IDEXX Laboratories
(11:33)
VVS Cardiology Webinar - 'Physical exam... is it cardiac?' with Dr Brigite Pedro
(1:16:31)
Enhancing mRNA Production with Advanced Analytics: WACKER Biotech
(54:)
Impact Research Webinar | episode 19 (Dr Julien Anract)
(30:44)
Perennial Breeding Spot Mapping and Role of VST,GPs and Blocks.
(9:41)
2024 MVSS VSIG Webinar
(58:6)
ESDR2019 Celgene Lecture: Arturo Zychlinsky \
(23:32)
3RsC Microphysiological Systems Workshop: Vascular MPS
(2:34)
Webinar Training and Retraining Best Practices
(53:8)
Volition webinar: Nu.Q NETs data insights
(57:12)
Rethinking the approach to diagnose cancer: VolitionRx Limited (NYSE AMERICAN: VNRX) 重塑癌症診斷方法
(15:51)
Volition’s Nu.Q(TM) Vet Assay Detects Two Common Canine Cancers
(2:26)
Unravelling the web of NETs in sepsis - webinar
(41:38)
Revolutionizing the Diagnosis of Life-altering Diseases 為重疾診斷技術帶來革命性突破 | VolitionRx (NYSE-A: VNRX)
(9:26)
Revolutionizing the Diagnosis of Life-altering Diseases - VolitionRx presents at GCFF June, 2022
(16:23)
VolitionRx Ltd. (NYSE MKT: VNRX) Webcast | SNN Network
(24:44)
VolitionRx Limited (NYSE American: VNRX) Webcast | Planet MicroCap Showcase: VEGAS 2023
(28:59)
RVN Webinar Series - A Reconstruction of Proto-Highland East Cushitic Phonology
(1:15:3)
VolitionRx Discusses $28 Million Licensing Deal with Heska and Focus for 2022
(4:53)
VolitionRx Provides Update on Animal Health Blood Test Program, Licensing Deals and Focus for 2021
(10:16)
Business Update and Dr Tom Butera Introduction
(11:50)